跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,258 条关于
“Aptar France S.A.S.”
全部
5,258
临床试验
3,877
药物
48
机构
165
资讯
1,168
11个月前
Nasus Pharma Partners with Aptar to Accelerate NS002 Intranasal Epinephrine Development
11天前
Aptar and Aceso Therapeutics Partner to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis
4天前
Aptar and Massachusetts General Hospital Partner to Build Predictive Nose-to-Brain Screening Platform for CNS Drugs
2个月前
Aptar Pharma Launches Integrated System-Level Framework to Support Injectable Drug Development
去年
Aptar Pharma Partners with Dianosic to Develop Novel Bioresorbable Intranasal Drug Delivery Platform
去年
Aptar Develops Dual-Active Material Science Technology for GLP-1 Drug Protection
去年
Aptar Pharma Acquires Mod3 Pharma's Clinical Trial Manufacturing Capabilities to Strengthen Early-Phase Drug Development Services
去年
Aptar Launches Clinical Study to Validate SmartTrack™ Platform for Accelerating Generic Inhaler Approvals
去年
AstraZeneca and Aptar Digital Health Partner to Develop AI Algorithms for Early Detection of Chronic Kidney Disease
去年
France Approves Johnson & Johnson's Single-Dose COVID-19 Vaccine
第 1 页,共 117 页
上一页
下一页